With Double Digit Growth Rates and Strong Product Pipeline, the Emerging Cardiac Devices Market will Witness a Transformation in the Next 5 Years
The biggest challenge for emerging cardiac procedures is adoption barrier and reimbursement. The long-term clinical evidence gathered through clinical studies and the technological improvement in the product pipeline has addressed the adoption barrier and reimbursement coverage based on morbidity of the patients is the first step towards increased adoption. The market trends, revenue forecasts, and competitive trends for each of the four segments are discussed in detail.
The research contains data about four of the emerging cardiac devices/procedures market. Cardiac Procedures developed conventionally was to address the cardiac condition. Today, most procedures and products developed are to address the ailment of the patients that cannot be supported with conventional procedures and devices. The market dynamics of these emerging procedures and devices are greatly determined the upcoming product launches and product pipeline.
The report encompasses an overview of emerging cardiac therapies with key findings. The emerging trends and technologies in the interventional cardiac sector and its potential market dynamics are also discussed. The analysis provides a roadmap for companies in cardiac sector to understand the emerging cardiac technologies and help them to prepare and stay competitive for the changing landscape of cardiac surgeries. Regions include United States and Western Europe (Germany, France, Spain, Italy, and the United Kingdom).
This report provides revenue forecasts, reimbursement trends, and top company profiles of key segments such as Transcatheter Aortic Valve Implantation (TAVI), Transcatheter Mitral Valve Repair (TMVR), Endovascular Aortic Repair (EVAR), and Left Ventricular Assisted device (LVAD).
Key Questions this Study will Answer - What are the technological evolutions in the cardiac procedures and how will they impact the overall cardiac sector? - Which are the most promising technologies in the emerging cardiac therapies? - How will the cardiac companies continue to exist through product innovations or inorganic growth? - What are the regulatory challenges faced by the device manufacturers? - Are the cardiac products offered today meeting customer needs or is additional development needed?
Our reports have been used by over 10K customers, including:
Microfluidics is the science and technology discipline of controlling fluids, usually in the range of microliters to picolitres, in networks of channels with lowest dimensions. The report “Microfluidics Market - By Material (Ceramics, Polymers), By Components (Microfluidic Chips, Pumps, Needles), By Application (In-Vitro...
Point-of-Care testing can be defined as the medical diagnostic testing performed outside the clinical laboratory near to the place where the patient is receiving treatment. This type of testing is performed by non-laboratory personnel and the results are used for clinical decision making. The Point-of-Care tests have...
With the rising population, increasing disposable income, and the structural shift in industrial sector in emerging economies, the energy consumption level increases, thereby widening the demand supply gap. This has led to increase in the usage of energy management systems in various industry verticals like power &...
The Global Navigation Satellite System (GNSS) industry plays a vital role in the ability of the countries to determine the position, velocity and local time from satellites in space. Over the past few years, the rapid growth in GNSS commercial applications has been observed by the firms building navigation satellites...
The insurance sector. 2017 was a good year for insurers operating in Poland. Premium written in non-life insurance surged by 18% YoY to nearly PLN 37.8 billion fuelled primarily by car insurance and benefiting from both higher tariffs and increasing number of insured cars. Also financial risks, health-related and property insurance sustained...
This new seven-country study contains 1,398 pages, 194 tables, and is designed to help current suppliers and potential market entrants identify and evaluate major business opportunities emerging in the molecular diagnostics market during the next five years.Highlights- Business and technological...
In Vitro Diagnostics
Date=201612 Publisher=Frost&Sullivan Price=5000
You can change your Cookie Settings at any time but parts of our site will not function correctly without them.